Oral presentation 3rd prize

Prijs: Prize (including medals and awards)

Description

A phase I clinical trial on intratumoral administration of autologous CD1c(BDCA-1)+ myeloid dendritic cells plus talimogene laherparepvec (T-VEC) in patients with advanced melanoma
Mate van erkenningNational

Toegekend op evenement

EvenementstitelBACR Annual Meeting 2020
LocatieVrije Universiteit Brussel, Campus Jette, Brussels, Belgium
Periode7 feb 2020 → 7 feb 2020

    Vingerafdruk